Skip to Content

93 7540 (Topiramate 50 mg)

Pill with imprint 93 7540 is Yellow, Capsule-shape and has been identified as Topiramate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of migraine prevention; bulimia; borderline personality disorder; seizures; seizure prevention (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7540

Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540

Topiramate

Imprint:
93 7540
Strength:
50 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
ferric oxide yellow
polyvinyl alcohol
magnesium silicate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide